TCNNF Trulieve Cannabis Corp.

MIXED Impact: 6/10 8-K
Horizon months Filed Jun 4, 2026 Processed 10d 22h ago SEC 0001754195-26-000033
8-K material event: Items 1.01, 2.01
Latest settled — T+1d
TCNNF ▲ +17.52% at T+1d
NEUTRAL call ✓ call won +17.52% · α vs SPY +20.12% · entry $9.99 → $11.74
Next anchor: T+5d due 4d ago
Last close $10.35 (close Jun 12) · +3.60% from $9.99 entry
Entry anchored
Jun 4, 2026
via day open
T+1d
+17.52%
call +17.52% · α +20.12%
$11.74
settled 10d ago
T+5d
call — · α —
due 4d ago
T+20d
call — · α —
in 18d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Trulieve deconsolidated its mixed-use cannabis subsidiary Harvest Enterprises, LLC, effective June 3, 2026, to segregate its medical and mixed-use cannabis businesses and pursue NYSE listing. Trulieve received $14.8 million in cash and retained a $188.5 million equity-method investment in Harvest, recognizing a $688.7 million non-cash loss on deconsolidation. Pro forma revenue for Q1 2026 drops from $286.8M to $214.0M, and the company's accumulated deficit increases to $437.5M.

Actionable Insight

The deconsolidation is a structural reorganization aimed at NYSE listing, not a fundamental business deterioration. Monitor for NYSE listing approval and any subsequent conversion of Harvest units. The $14.8M cash inflow and reduced asset base improve balance sheet simplicity but the $688.7M loss is a significant non-cash charge. The Protection Agreement provides downside protection for Trulieve's retained interest.

Key Facts

  • Deconsolidation of Harvest Enterprises, LLC closed on June 3, 2026, to separate mixed-use cannabis from medical cannabis for NYSE listing application.
  • Trulieve received $14.8 million cash consideration and recognized a retained investment in Harvest at $188.5 million estimated fair value.
  • A $688.7 million pre-tax loss on deconsolidation was recorded, reflecting the difference between net assets disposed ($889.7M) and consideration plus retained investment ($203.3M).
  • Pro forma Q1 2026 revenue declines from $286.8 million to $214.0 million; pro forma net income from continuing operations is $5.9 million vs. $3.4 million as reported.
  • Non-voting, non-participating units held by Trulieve in Harvest are convertible into Class B units only after NYSE permits listing of companies consolidating mixed-use cannabis operators.
  • A Protection Agreement restricts Harvest LLC from taking actions that erode the value of Trulieve's exchangeable units, including limits on dividends, debt, and asset sales.
  • Trulieve's pro forma accumulated deficit increases to $437.5 million from $909.7 million as reported, primarily due to the deconsolidation loss.
  • The deconsolidation reduces total assets from $2.78 billion to $2.10 billion and total liabilities from $1.63 billion to $1.26 billion on a pro forma basis.

Financial Impact

Q1 2026 pro forma revenue declines by $72.7M (25.4%) to $214.0M; pro forma net income from continuing operations improves by $2.5M to $5.9M. A $688.7M non-cash loss on deconsolidation is recognized, increasing accumulated deficit by $201.0M to $437.5M.

revenuenet incomeaccumulated deficittotal assetstotal liabilitiescash and cash equivalents

Risk Factors

  • NYSE may not permit listing of companies consolidating mixed-use cannabis operators, delaying or preventing the intended conversion of Harvest units.
  • The $688.7M non-cash loss on deconsolidation may raise accounting scrutiny or impair investor confidence.
  • Pro forma revenue decline of 25% reflects loss of Harvest's mixed-use revenue stream, reducing top-line scale.
  • Regulatory approvals for transfer of certain businesses to Harvest remain pending, creating uncertainty.
  • The Protection Agreement's dividend caps and debt restrictions may limit Harvest LLC's operational flexibility.

Market Snapshot

Exchange
OTC
Sector
Medicinal Chemicals & Botanical Products
Analyst Consensus
92% bullish (13 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001754195-26-000033
Document: limitedliabilitycompanya.htm0001754195-26-000033
Document: protectionagreementdated.htm0001754195-26-000033
5 reports for TCNNF
Performance horizon
Filters
Rows
Reports for TCNNF — sortable, filterable
Type Now
Jun 9, 2026
5d ago
8-K
NEUTRAL ★ 4/10
$12.15 awaiting T+1awaiting T+1$10.35 (−14.81%)
Jun 4, 2026
10d ago
8-K
MIXED ★ 6/10
$9.99 $11.74▲ +17.52%▲ +20.12%$10.35 (+3.60%)
May 7, 2026
5w ago
8-K
MIXED ★ 5/10
$9.31 $8.80▼ −5.48%▼ −6.31%$10.35 (+11.17%)
Apr 29, 2026
6w ago
DEFA14A
NEUTRAL ★ 2/10
$9.84 $9.59▼ −2.54%▼ −2.76%$10.35 (+5.18%)
Mar 5, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$6.61 $6.40▼ −3.18%▼ −4.02%$10.35 (+56.58%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 4h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access